Yiling Pharmaceutical Inc.: Clinical Trials

5 trials sponsored by Yiling Pharmaceutical Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Yiling Pharmaceutical Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Pharmacokinetics Study for KT07 Capsule
Low dose KT07, High dose KT07, Low dose Placebo - Healthy Adult Subjects, Pharmacokinetics
Phase 1CompletedYiling Pharmaceutical Inc.262022-01-072022-10-17
A Clinical Study Trial of Phenlarmide in China
Phenlarmide Tablets, Placebos - Parkinson Disease
Phase 1CompletedYiling Pharmaceutical Inc.362019-12-172021-12-14
A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China
Finamine tablets, Placebo tablets - Parkinson Disease
Phase 1CompletedYiling Pharmaceutical Inc.342017-08-152021-12-14
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China
Felbinac Trometamol Injection, Placebo - Healthy
Phase 1CompletedYiling Pharmaceutical Inc.582017-07-172019-11-18
A Clinical Trial of KT07 Capsule in the U.S.A
KT07 Capsule, Placebo - Influenza, Human
Phase 2CompletedYiling Pharmaceutical Inc.3912016-09-012020-08-31

Conditions studied

Parkinson Disease (2)  ·  Influenza, Human (1)

Interventions

Saline Solution (1)

Countries

China (3)  ·  United States (2)

Top investigators

Nan Zhang, PhD (1)  ·  Xuedong Gao, MD (1)  ·  Yanhua Ding, MD (1)